United States:
Pfizer Announces Its Vaccine May Soon Be Administered To Children
07 May 2021
McLane Middleton, Professional Association
To print this article, all you need is to be registered or login on Mondaq.com.
The Chairman and CEO of Pfizer announced on Tuesday, May 4, that
it expects the FDA to expand Emergency Use Authorization, allowing
children ages 12-15 to receive its vaccine. Previously, the cut-off
age was 16, but Pfizer has stated that the results of testing of
its vaccine will allow the younger-aged children to safely receive
the vaccine. Pfizer expects FDA approval as early as next week.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Healthcare Policy Developments To Watch In 2024
Crowell & Moring LLP
The ever-changing healthcare policy landscape will witness at the federal level regulatory changes driven by the need to transform healthcare delivery, quality and innovation.
The FDA And The Future Of AI Oversight
Manatt, Phelps & Phillips LLP
In January 2024, the U.S. Government Accountability Office (GAO) issued a report highlighting current obstacles to the U.S. Food and Drug Administration's (FDA) timely and effective regulation...